Scientific news
Latest news, scientific publications and events
SUDOSCAN technology in “Advances in Biosensors: Reviews – vol 3”
SUDOSCAN technology explained in “Advances in Biosensors” A whole sharply detailed chapter explaining SUDOSCAN technology, is available in Advances in Biosensors: Reviews, volume 3 (Segey Y. Yurish, Editor), an IFSA Publishing Open Access Books. First, this Chapter presents key information about the physiology of sweat glands and their control via small C fibers releasing Cholinergic
Impeto Medical 15th anniversary
This year Impeto Medical celebrates its 15th anniversary Over the past 15 years, the company has made remarkable progress in R&D and sales, with more than 3,500 units sold and several million tests per year in 40 countries around the world, more than 150 articles published in peer-reviewed journals and 15 patents filed.Considering the
SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020
Multidisciplinary French speaking day of Amyloidosis – JFMA 2020 Last month, SUDOSCAN was presented at the virtual Multidisciplinary French speaking day of Amyloidosis. The congress gathered 300 participants with a large scientific program on the different amyloidosis types. Amyloidosis is an acquired or hereditary rare disease due to amyloid protein deposits into organs. Several types
SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy
SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 DIABETES WITHOUT CLINICAL EVIDENCE OF PERIPHERAL NEUROPATHY Danyelle Lorrane Carneiro Veloso, Raira Castilho Gomes Nascimento, Eliziane Brandao Leite, Luisiane de Avila Santana, Angelica Amorim Amato.Article title: Predictors of sudomotor dysfunction in patients with type 1 diabetes without clinical evidence of peripheral neuropathy.Diabetes Research and Clinical
Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN
CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP BY SUDOSCAN A. Syngle, S. Chahal, K. Vohra. Article title: Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurological Sciences. 2020 Aug 15. A new publication by Syngle et al. in Neurological
SUDOSCAN combined to other diagnosis tests to confirm small fiber neuropathy
SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S. M. Evrard and A. Pavy-Le Traon.Article title: “Which Method for Diagnosing Small Fiber Neuropathy?”Front. Neurol., 05 May 2020. In a recent study conducted at Toulouse University Hospital, France, Vincent FABRY
